Indo MIM and Laser Power & Infra have filed draft papers with Sebi for IPOs worth over Rs 2,200 crore. Proceeds will primarily go toward debt repayment and growth, with both firms leveraging strong industry positioning and robust financial performance.
Indian equities posted their steepest weekly fall in seven months as the Sensex and Nifty extended losses amid U.S. visa curbs and drug tariffs. Pharma and IT stocks dragged, while FIIs stayed cautious. Analysts flagged key support at 24,500, with volatility expected around monthly expiry and global uncertainties weighing on sentiment.
As housing prices skyrocket in a gentrifying Chicago neighborhood, living in the family home is one way for young Latino adults to stay in their community.
Warren Buffetts Berkshire Hathaway has fully sold its 17-year stake in Chinese electric-vehicle maker BYD, ending one of the most profitable foreign bets in the conglomerates history.
Tata Capital is launching Indias largest financial-sector IPO on October 6, aiming for a valuation of around $18 billion. The Rs 17,200 crore issue includes a fresh share sale and OFS by Tata Sons and IFC. Proceeds will bolster Tier-1 capital, fulfilling RBIs listing mandate. Strong FY25 profits and wide retail presence support the investment case, while unlisted shares trade 33% below last years peak.
The Nifty extended its losing streak with a sixth consecutive decline, slipping below the 25,000 support level amid broad-based selling, especially in pharma and IT stocks. Analysts warn of further downside if 24,500 breaks, though a recovery remains possible. Stock recommendations include Ashok Leyland, Dr Agarwals Health Care, Dixon, and Anant Raj.
Precision components maker Indo MIM has filed preliminary papers with markets regulator Sebi to raise funds through an initial public offering (IPO) comprising a fresh issue of equity shares worth Rs 1,000 crore.
